Unlock stock picks and a broker-level newsfeed that powers Wall Street.
5.16
-0.54
(-9.47%)
At close: April 4 at 4:00:01 PM EDT
5.14
-0.02
(-0.39%)
After hours: April 4 at 5:23:49 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.61 | -0.61 | -2.35 | -1.5 |
| Low Estimate | -0.61 | -0.61 | -2.35 | -1.5 |
| High Estimate | -0.61 | -0.61 | -2.35 | -1.5 |
| Year Ago EPS | -0.98 | -0.61 | -3.01 | -2.35 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 8 | 7 |
| Avg. Estimate | -- | 5.83M | 24.4M | 83.75M |
| Low Estimate | -- | -- | 5.43M | 27.8M |
| High Estimate | -- | 35M | 83.5M | 168.4M |
| Year Ago Sales | -- | 10M | 10M | 24.4M |
| Sales Growth (year/est) | 0.00% | -41.67% | 143.98% | 243.28% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.87 | -1.06 | -0.82 | -0.74 |
| EPS Actual | -0.98 | -0.61 | -0.88 | -0.6 |
| Difference | -0.11 | 0.45 | -0.06 | 0.14 |
| Surprise % | -13.08% | 42.59% | -7.32% | 18.55% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.61 | -0.61 | -2.35 | -1.5 |
| 7 Days Ago | -0.81 | -0.75 | -2.8 | -1.45 |
| 30 Days Ago | -0.81 | -0.75 | -2.8 | -1.45 |
| 60 Days Ago | -0.81 | -0.75 | -2.8 | -1.45 |
| 90 Days Ago | -0.81 | -0.75 | -2.37 | -1.36 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | -- |
| Up Last 30 Days | 1 | -- | -- | -- |
| Down Last 7 Days | -- | 1 | -- | 1 |
| Down Last 30 Days | -- | 1 | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VSTM | 37.76% | 0.00% | 21.93% | 36.17% |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
| Maintains | Guggenheim: Buy to Buy | 3/24/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/24/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 3/21/2025 |
| Maintains | B. Riley Securities: Buy to Buy | 1/31/2025 |
| Reiterates | Guggenheim: Buy to Buy | 1/24/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 1/7/2025 |
Related Tickers
CRDF Cardiff Oncology, Inc.
2.7500
-4.18%
ABEO Abeona Therapeutics Inc.
4.5200
-8.69%
REPL Replimune Group, Inc.
7.46
-5.45%
KPTI Karyopharm Therapeutics Inc.
3.8600
0.00%
IMUX Immunic, Inc.
0.9950
-5.24%
RGNX REGENXBIO Inc.
6.29
-5.70%
URGN UroGen Pharma Ltd.
10.25
-2.66%
KALV KalVista Pharmaceuticals, Inc.
10.71
-5.39%
TENX Tenax Therapeutics, Inc.
5.80
-3.33%
DAWN Day One Biopharmaceuticals, Inc.
7.22
-6.36%